Literature DB >> 2442630

Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle.

G Scholtysik.   

Abstract

Electrophysiological effects of the 5-HT3 receptor antagonist ICS 205-930 [(3 alpha-tropanyl)-1H-indole-3-carboxylic acid ester] were investigated in guinea pig isolated heart preparations. ICS 205-930 prolonged the functional refractory period and decreased the force of contraction in left driven atria. It decreased spontaneous beating rate in right atria. These effects were concentration dependent between 3 X 10(-6) and 10(-4) mol/l of ICS 205-930. In fast action potentials of papillary muscles ICS 205-930 concentration-dependently depressed Vmax and prolonged the action potential duration (APD) between 10(-6) and 10(-5) mol/l. The action potential amplitude (APA) and the resting membrane potential (RMP) remained unchanged. In papillary muscles partially depolarized by high K+ (22 mmol/l) and reactivated by high voltage stimulation, slow response APs were prolonged by ICS 205-930 10(-6) to 3 X 10(-5) mol. Vmax, APA and RMP were not affected. Similar effects on APD were obtained with sotalol (3 X 10(-5) mol/l), an inhibitor of outward K+ current. The slow-APD prolongation induced by ICS 205-930 as well as by sotalol was reversed by BRL 34915 (6-cyano-3,4-dihydro-2,2-dimethyltrans-4-(2-oxo-1-pyrrolidyl )-2H-benzo[b]pyran-3-ol), known to open K+ channels. BRL 34915 alone reduced slow-APD stereoselectively. The results suggest that ICS 205-930 may inhibit and BRL 34915 may stimulate the K+ conductance of guinea pig myocardial cell membranes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442630     DOI: 10.1007/bf00166988

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Authors:  M B Bacaner; J R Clay; A Shrier; R M Brochu
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

2.  The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels.

Authors:  S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 3.  Properties of two inward membrane currents in the heart.

Authors:  H Reuter
Journal:  Annu Rev Physiol       Date:  1979       Impact factor: 19.318

4.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

5.  Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.

Authors:  J J Lynch; D J Wilber; D G Montgomery; T M Hsieh; E Patterson; B R Lucchesi
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

6.  Two classes of myocardial 5-hydroxytryptamine receptors that are neither 5-HT1 nor 5-HT2.

Authors:  A J Kaumann
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

7.  An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.

Authors:  K A Kane; J R Parratt; F M Williams
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

8.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.

Authors:  S Imanishi; M Arita; T Kiyosue; M Aomine
Journal:  J Pharmacol Exp Ther       Date:  1983-04       Impact factor: 4.030

10.  The effects of ICS 205-930, a 5-HT antagonist, on arrhythmias and catecholamine release during canine myocardial ischaemia and reperfusion.

Authors:  S J Coker; H G Dean; K A Kane; J R Parratt
Journal:  Eur J Pharmacol       Date:  1986-08-15       Impact factor: 4.432

View more
  19 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Ionic currents contributing to the action potential in single ventricular myocytes of the guinea pig studied with action potential clamp.

Authors:  T Doerr; R Denger; A Doerr; W Trautwein
Journal:  Pflugers Arch       Date:  1990-05       Impact factor: 3.657

Review 3.  The pharmacology of ATP-sensitive K+ channels in the heart.

Authors:  D Escande
Journal:  Pflugers Arch       Date:  1989       Impact factor: 3.657

4.  Action of cromakalim on potassium membrane conductance in isolated heart myocytes of frog.

Authors:  R Pilsudski; O Rougier; Y Tourneur
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.

Authors:  G A McPherson; J A Angus
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

6.  BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle.

Authors:  M C Sanguinetti; A L Scott; G J Zingaro; P K Siegl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.

Authors:  K A Wardle; E S Ellis; G S Baxter; G A Kennett; L M Gaster; G J Sanger
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

9.  Inhibition of the 5-HT-induced cardiogenic hypertensive chemoreflex by the selective 5-HT3 receptor antagonist ICS 205-930.

Authors:  H Berthold; G Scholtysik; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

10.  Baroreflex and beta-adrenoceptor function are diminished in rat cardiac hypertrophy due to volume overload.

Authors:  K Umemura; W Zierhut; U Quast; R P Hof
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.